Efficacy and Safety of the Traditional Herbal Medicine, Gamiguibi-tang, in Patients With Cancer-Related Sleep Disturbance: A Prospective, Randomized, Wait-List-Controlled, Pilot Study.

Abstract:

BACKGROUND:Sleep disturbance is the second most bothersome symptom in patients with cancer, and it can significantly impair their quality of life. The aim of this study was to investigate the efficacy and safety of the traditional herbal medicine Gamiguibi-tang (GGBT) in patients with cancer-related sleep disturbance. METHODS:We conducted a prospective, randomized, wait-list-controlled, open-label pilot clinical trial on cancer-related sleep disturbance. Patients with cancer experiencing poor sleep quality with a Pittsburgh Sleep Quality Index of at least 6 were randomly assigned to the GGBT and wait-list groups to receive GGBT and conventional care, respectively, for 2 weeks. The primary endpoint was the Insomnia Severity Index (ISI) score. Fatigue, depression, and cognitive impairment were assessed as the secondary endpoints by using the Brief Fatigue Inventory (BFI), Beck Depression Inventory (BDI), and Montreal Cognitive Assessment (MoCA). RESULTS:Thirty participants who met the eligibility criteria were enrolled. Sleep disturbance assessed using the ISI improved significantly more in the GGBT group than in the wait-list group (-5.5 ± 4.4 vs 0.1 ± 1.1, P < .001). Fatigue level determined using the BFI also improved significantly more in the GGBT group than in the wait-list group (-0.8 ± 0.8 vs 0.0 ± 0.3, P = .002). The BDI and MoCA scores showed no significant changes. Adverse events were reported in two patients in the GGBT group and consisted of mild dyspepsia and mild edema. CONCLUSION:GGBT may be a potential treatment option for cancer-related sleep disturbance. Further research is needed to investigate the efficacy and safety of GGBT.

journal_name

Integr Cancer Ther

authors

Lee JY,Oh HK,Ryu HS,Yoon SS,Eo W,Yoon SW

doi

10.1177/1534735417734914

subject

Has Abstract

pub_date

2018-06-01 00:00:00

pages

524-530

issue

2

eissn

1534-7354

issn

1552-695X

journal_volume

17

pub_type

杂志文章
  • A Polyphenol-Rich Extract From Muscadine Grapes Inhibits Triple-Negative Breast Tumor Growth.

    abstract::Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that tends to affect young women and has a high propensity to metastasize. No targeted treatments are available for this type of breast cancer due to a lack of estrogen or progesterone receptors or overexpression of human epidermal growth f...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735420917444

    authors: Collard M,Gallagher PE,Tallant EA

    更新日期:2020-01-01 00:00:00

  • An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients.

    abstract:BACKGROUND:Conventional anticancer therapies still cause difficulties with selective eradication and accompanying side effects that reduce patients' quality of life (QOL). Fucoidan is extracted from seaweeds and has already exhibited broad bioactivities, including anticancer and anti-inflammatory properties, in basic s...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735417692097

    authors: Takahashi H,Kawaguchi M,Kitamura K,Narumiya S,Kawamura M,Tengan I,Nishimoto S,Hanamure Y,Majima Y,Tsubura S,Teruya K,Shirahata S

    更新日期:2018-06-01 00:00:00

  • Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury.

    abstract::Many plant products are known to exert antioxidative effects by quenching various free radicals and singlet molecular oxygen. Andrographis paniculata (Kalmegh) is used extensively in the Indian traditional system of medicine as a hepatoprotective and hepatostimulative agent and has been reported to have antioxidant ef...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735407305985

    authors: Trivedi NP,Rawal UM,Patel BP

    更新日期:2007-09-01 00:00:00

  • Can a cancer program-sponsored spiritual event meet with acceptance from patients and other attendees?

    abstract:BACKGROUND:While many cancer patients derive strength from spiritual or religious faith, concern often remains regarding how different patient subgroups and other community members might react to faith-based services when sponsored by a secular health care organization. METHODS:"A Sacred Gathering for Those Touched by...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735405278640

    authors: Dann NJ,Higby DJ,Mertens WC

    更新日期:2005-09-01 00:00:00

  • Impact of Oncological Therapy and Viscum album L Treatment on Cancer-Related Fatigue and Internal Coherence in Nonmetastasized Breast Cancer Patients.

    abstract::Introduction:Viscum album L extracts (VA) are frequently used in integrative oncology. Aim of this study was to evaluate the impact of add-on VA applications on various patient-reported outcome measures. Methods: A longitudinal real-world study was conducted, using data from the Network Oncology clinical registry. Pri...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735420917211

    authors: Oei SL,Thronicke A,Kröz M,von Trott P,Schad F,Matthes H

    更新日期:2020-01-01 00:00:00

  • Shedding light on vitamin D and integrative oncology.

    abstract::Studies show an important relationship between vitamin D and malignancies, both in prevention and treatment. The extraskeletal actions of vitamin D relevant to oncology include being proapoptotic, antimetastatic, antiangiogenic, antiinflammatory, prodifferentiating, and immunomodulating. Widespread and severe vitamin ...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735408319062

    authors: Cantor I

    更新日期:2008-06-01 00:00:00

  • Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach.

    abstract::Oncology is currently a sector of medical science with accelerated progress due to rapid technological development, the advancement in molecular biology, and the invention of many innovative therapies. Immunotherapy partially accounts for this advance, since it is increasingly playing an important role in the treatmen...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735419827090

    authors: Nikolaou M,Nikolaou G,Digklia A,Pontas C,Tsoukalas N,Kyrgias G,Tolia M

    更新日期:2019-01-01 00:00:00

  • Influence of a Multidisciplinary Program of Diet, Exercise, and Mindfulness on the Quality of Life of Stage IIA-IIB Breast Cancer Survivors.

    abstract::Background: Integrative oncology has proven to be a useful approach to control cancer symptoms and improve the quality of life (QoL) and overall health of patients, delivering integrated patient care at both physical and emotional levels. The objective of this randomized trial was to evaluate the effects of a triple i...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735420924757

    authors: Ruiz-Vozmediano J,Löhnchen S,Jurado L,Recio R,Rodríguez-Carrillo A,López M,Mustieles V,Expósito M,Arroyo-Morales M,Fernández MF

    更新日期:2020-01-01 00:00:00

  • Eupatorin Suppressed Tumor Progression and Enhanced Immunity in a 4T1 Murine Breast Cancer Model.

    abstract::Eupatorin is a polymethoxy flavone extracted from Orthosiphon stamineus and was reported to exhibit cytotoxic effects on several cancer cell lines. However, its effect as an anti-breast cancer agent in vivo has yet to be determined. This study aims to elucidate the potential of eupatorin as an anti-breast cancer agent...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735420935625

    authors: Abd Razak N,Yeap SK,Alitheen NB,Ho WY,Yong CY,Tan SW,Tan WS,Long K

    更新日期:2020-01-01 00:00:00

  • Survey of Policies and Guidelines on Antioxidant Use for Cancer Prevention, Treatment, and Survivorship in North American Cancer Centers: What Do Institutions Perceive as Evidence?

    abstract:BACKGROUND:Health care policies and guidelines that are clear and consistent with research evidence are important for maximizing clinical outcomes. To determine whether cancer centers in Canada and the United States had policies and/or guidelines about antioxidant use, and whether policies were aligned with the evidenc...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735415572884

    authors: Hong G,White J,Zhong L,Carlson LE

    更新日期:2015-07-01 00:00:00

  • Herbal Medicine for Xerostomia in Cancer Patients: A Systematic Review of Randomized Controlled Trials.

    abstract:BACKGROUND:Xerostomia (dry mouth) causes many clinical problems, including oral infections, speech difficulties, and impaired chewing and swallowing of food. Many cancer patients have complained of xerostomia induced by cancer therapy. OBJECTIVE:The aim of this systematic review is to assess the efficacy of herbal med...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735417728336

    authors: Park B,Noh H,Choi DJ

    更新日期:2018-06-01 00:00:00

  • Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis.

    abstract:BACKGROUND:Chemoradiotherapy-associated mucositis can manifest as pain, inflammation, dysphagia, diarrhea, weight loss, rectal bleeding, and infection. Mucositis is a major dose-limiting side effect of chemotherapy, affecting nutritional intake and oral and intestinal function. Despite several interventions being avail...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735418794885

    authors: Thomsen M,Vitetta L

    更新日期:2018-12-01 00:00:00

  • Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

    abstract::Although localized colon cancer is often successfully treated with surgery, advanced disease requires aggressive systemic therapy that has lower effectiveness. Approximately 30% to 75% of patients with colon cancer use complementary and alternative medicine (CAM), but there is limited formal evidence of survival effic...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735411406539

    authors: McCulloch M,Broffman M,van der Laan M,Hubbard A,Kushi L,Abrams DI,Gao J,Colford JM Jr

    更新日期:2011-09-01 00:00:00

  • Physical Activity Behavior After a Diagnosis of Lung Cancer Differs Between Countries: An Observational Cohort Study.

    abstract:INTRODUCTION:Physical activity (PA) is important in lung cancer. OBJECTIVES:To investigate PA levels and health-related quality of life (HRQoL) of patients with lung cancer in China and compare this to a similar cohort in Australia. METHODS:Prospective cohort study. 71 patients from China (group CH) and 90 patients f...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735417699513

    authors: Ni J,Denehy L,Feng J,Xu L,Wu Y,Granger CL

    更新日期:2018-06-01 00:00:00

  • Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study.

    abstract:BACKGROUND:Many patients with cancer seek complementary and alternative medicine treatments. We investigated the use of traditional Chinese medicine (TCM) by adult cancer patients in Taiwan. METHODS:We reviewed the Registry for Catastrophic Illness Patients Database of Taiwan, and included all adult patients diagnosed...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735417716302

    authors: Kuo YT,Chang TT,Muo CH,Wu MY,Sun MF,Yeh CC,Yen HR

    更新日期:2018-06-01 00:00:00

  • A model program: exercise intervention for cancer rehabilitation.

    abstract::Recent advances in cancer detection and treatment have resulted in an increase in the survival rate of individuals diagnosed with cancer. The increased survival rate brings new challenges for increasing the quality of life for cancer survivors. Debilitating side effects can result from the cancer itself and the cancer...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章,评审

    doi:10.1177/153473540200100117

    authors: Schneider CM,Dennehy CA,Roozeboom M,Carter SD

    更新日期:2002-03-01 00:00:00

  • Effect of botanical immunomodulators on human CYP3A4 inhibition: implications for concurrent use as adjuvants in cancer therapy.

    abstract:PURPOSE:Many botanical immunomodulators are used as adjuvants along with cancer chemotherapy. However, information on the impact of concurrent administration of such botanicals on pharmacokinetics of chemotherapy agents is inadequate. This study investigates inhibitory activities of 3 popular botanical adjuvants: ASPAR...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735413503551

    authors: Patil D,Gautam M,Gairola S,Jadhav S,Patwardhan B

    更新日期:2014-03-01 00:00:00

  • Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies.

    abstract::Extracts of milk thistle have been recognized for centuries as "liver tonics" and are well-known to prevent or reverse hepatotoxicity of reactive drug metabolites or naturally occurring toxins. Milk thistle extracts are now under intense study in the experimental therapeutics of cancer for chemoprevention, treatment, ...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章,评审

    doi:10.1177/1534735407301825

    authors: Kroll DJ,Shaw HS,Oberlies NH

    更新日期:2007-06-01 00:00:00

  • Elimination of cancer stem-like side population in human glioblastoma cells accompanied with stemness gene suppression by Korean herbal recipe MSC500.

    abstract:BACKGROUND:High-grade gliomas are the most common and invasive malignant brain tumors in adults, and they are almost universally fatal because of drug resistance and recurrence. In spite of the progress in adjuvant therapy (like temozolomide) and irradiation after surgery, no effective salvage therapy is currently avai...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735414549623

    authors: Yao CJ,Han TY,Shih PH,Yi TY,Lai IC,Chang KH,Lai TY,Chang CL,Lai GM

    更新日期:2014-11-01 00:00:00

  • Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.

    abstract::Gastric cancer (GC) is a malignancy with few effective treatment options after metastasis occurs. Quercetin (Qu) intake has been associated with reduced incidence and slow development of GC, probably due to its anti-proliferative and apoptotic effects, but it is unclear whether Qu can inhibit the metastatic activity. ...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735417696702

    authors: Li H,Chen C

    更新日期:2018-06-01 00:00:00

  • Forming a Stress Management and Health Promotion Program for Women Undergoing Chemotherapy for Breast Cancer: A Pilot Randomized Controlled Trial.

    abstract:OBJECTIVE:To assess the effects of an 8-week stress management and health promotion program on women undergoing breast cancer chemotherapy treatment. Patients and methods A total of 61 patients were recruited in 2 cancer centers and were randomly assigned to the intervention program (n = 30) or control group (n = 31). ...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1534735415598225

    authors: Pelekasis P,Zisi G,Koumarianou A,Marioli A,Chrousos G,Syrigos K,Darviri C

    更新日期:2016-06-01 00:00:00

  • Inhibition to Epithelial-Mesenchymal Transition and Metastatic Potential In Colorectal Cancer Cell By Combination of Traditional Chinese Medicine Formulation Jiedu Sangen Decoction and PD-L1 Inhibitor.

    abstract:BACKGROUND:Jiedu Sangen Decoction (JSD), a traditional Chinese medicine formula, has been widely applied in the treatment of gastrointestinal cancer, especially in colorectal cancer. Our study mainly aimed to assess the combined efficacy of Jiedu Sangen aqueous extract (JSAE) and a PD-L1 inhibitor (PI) in colon cancer ...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735420972486

    authors: Shan F,Sun L,Zhang L,Guo K,Yan Q,Feng G,Zhu Y,Shen M,Ruan S

    更新日期:2020-01-01 00:00:00

  • Conventional Western Treatment Associated With Chinese Herbal Medicine Ameliorates the Incidence of Head and Neck Cancer Among Patients With Esophageal Cancer.

    abstract:BACKGROUND:Because of advances in medical treatment, the survival of cancer patients is prolonged. In line with the prolonged survival time of cancer the incidence of second primary cancer has increased. There is currently no effective way to prevent the occurrence of secondary primary cancer (SPC). OBJECTIVES:The aim...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735419834353

    authors: Chang CC,Bi KW,Lin HJ,Su YC,Wang WL,Lin CY,Ting CF,Sun MF,Huang ST

    更新日期:2019-01-01 00:00:00

  • Assessing the Correlation Between Physical Activity and Quality of Life in Advanced Lung Cancer.

    abstract:BACKGROUND AND OBJECTIVE:Increasing physical activity (PA) is safe and beneficial in lung cancer (LC) patients. Advanced-stage LC patients are under-studied and have worse symptoms and quality of life (QoL). We evaluated the feasibility of monitoring step count in advanced LC as well as potential correlations between P...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735416684016

    authors: Bade BC,Brooks MC,Nietert SB,Ulmer A,Thomas DD,Nietert PJ,Scott JB,Silvestri GA

    更新日期:2018-03-01 00:00:00

  • Integrative tumor board: a case report and discussion from East-West Cancer Center.

    abstract:AIM:To introduce the application of wheel balance cancer therapy (WBCT) in cancer treatment through an intensive study of a representative patient. METHOD:A 59-year-old, female patient who was a secondhand smoker and who carried no significant medical and family history was diagnosed with T1N0M1 (stage 4) lung adenoca...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735410371479

    authors: Park HM,Kim SY,Jung IC,Lee YW,Cho CK,Yoo HS

    更新日期:2010-06-01 00:00:00

  • Communication in cancer care: discussing complementary and alternative medicine.

    abstract::In recent years, there has been an increased interest in complementary and alternative medicine (CAM) use among people with cancer. Many are looking for informed advice and desire communication with their physicians about CAM use. Communication is crucial in establishing trust with patients, gathering information, add...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章,评审

    doi:10.1177/1534735410363706

    authors: Frenkel M,Ben-Arye E,Cohen L

    更新日期:2010-06-01 00:00:00

  • Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells.

    abstract::Lung cancer is the leading cause of cancer death worldwide, and most chemotherapeutic drugs have limited success in treating this disease. Furthermore, some drugs show undesirable side effects due to the enrichment of cancer stem cells (CSCs) that are present, leading to resistance to conventional chemotherapy and tum...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735414534462

    authors: Kim M,Kim YS,Kim KM,Ko HC,Kim SJ,Kim JH,Kim Y

    更新日期:2014-11-01 00:00:00

  • Feasibility trial of electroacupuncture for aromatase inhibitor--related arthralgia in breast cancer survivors.

    abstract:BACKGROUND:Arthralgia affects postmenopausal women receiving aromatase inhibitors (AIs) for breast cancer. Given the existing evidence for electroacupuncture (EA) for treatment of osteoarthritis in the general population, this study aims to establish the feasibility of studying EA for treating AI-related arthralgia. P...

    journal_title:Integrative cancer therapies

    pub_type: 临床试验,杂志文章

    doi:10.1177/1534735409332903

    authors: Mao JJ,Bruner DW,Stricker C,Farrar JT,Xie SX,Bowman MA,Pucci D,Han X,DeMichele A

    更新日期:2009-06-01 00:00:00

  • Surviving against all odds: analysis of 6 case studies of patients with cancer who followed the Gerson therapy.

    abstract::A considerable number of patients with cancer have used or are using the Gerson therapy, an alleged anticancer metabolic diet. However, there is almost no scientific support for this regimen. Hence, the present case review study of 6 patients with metastatic cancer who used the Gerson therapy aims at critically evalua...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735406298258

    authors: Molassiotis A,Peat P

    更新日期:2007-03-01 00:00:00

  • Protective effect of Andrographis paniculata and andrographolide on cyclophosphamide-induced urothelial toxicity.

    abstract::The protective effect of Andrograhis paniculata and andrographolide (ANDLE) against cyclophosphamide (CTX)-induced urothelial toxicity was investigated in this study. Pretreatment of Swiss albino mice with A paniculata extract (10 mg/dose/animal intraperitoneally [ip]) and ANDLE (500 microg/dose/animal ip) could signi...

    journal_title:Integrative cancer therapies

    pub_type: 杂志文章

    doi:10.1177/1534735406291984

    authors: Sheeja K,Kuttan G

    更新日期:2006-09-01 00:00:00